Amanote Research

Amanote Research

    RegisterSign In

Improving Combination Cancer Therapy: The CombiPlex® Development Platform

Future Oncology - United Kingdom
doi 10.2217/fon-2017-0607
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineCancer ResearchOncology
Date

June 1, 2018

Authors
Anthony W TolcherLawrence D Mayer
Publisher

Future Medicine Ltd


Related search

Development of a Nanotechnology Platform for Prostate Cancer Gene Therapy

2011English

Versatile Nanodelivery Platform to Maximize siRNA Combination Therapy

Macromolecular Bioscience
PlasticsPolymersMaterials ChemistryBiomaterialsBioengineeringBiotechnology
2016English

Bladder Cancer: Principles of Combination Therapy

British Journal of Cancer
Cancer ResearchOncology
1982English

Fabrication of PEGylated Bi2S3 Nanosheets as a Multifunctional Platform for Multimodal Diagnosis and Combination Therapy for Cancer

English

Hybrid Nanoparticles for Combination Therapy of Cancer

Journal of Controlled Release
Pharmaceutical Science
2015English

Nanoparticles for Effective Combination Therapy of Cancer

International Journal of Nanotechnology and Nanomedicine
2016English

Development of a Combination Therapy for Prostate Cancer by Targeting Stat3 and HIF-1alpha

2013English

Adjunct Therapy During Combination Chemotherapy for Colorectal Cancer

Onkologiya. Zhurnal imeni P.A.Gertsena
2016English

Therapeutic Cancer Vaccines in Combination With Conventional Therapy

Journal of Biomedicine and Biotechnology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy